| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGGCGGUC… | 1987 nt | 0.4892 | |
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGAUUCCC… | 1412 nt | 0.4207 | |
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGGCGGUC… | 1913 nt | 0.4867 | |
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGGCGGUC… | 1587 nt | 0.4549 | |
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGGCGGUC… | 1691 nt | 0.4548 | |
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGGCGGUC… | 1855 nt | 0.4911 | |
| AGAGGACAGGGUUGCGGCGGGCGGAACGGUGUCUCCUUCACUUCGCCCU… | 1512 nt | 0.4431 | |
| CUCUCAGGCACACAACCCAGCACAGCAAGGCAGUCACACCAAGGCGGUC… | 1809 nt | 0.4887 |
This gene encodes a member of the voltage-dependent anion channel pore-forming family of proteins that are considered the main pathway for metabolite diffusion across the mitochondrial outer membrane. The encoded protein is also thought to be involved in the mitochondrial apoptotic pathway via regulation of BCL2-antagonist/killer 1 protein activity. Pseudogenes have been identified on chromosomes 1, 2, 12 and 21, and alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
A study in humans and mice demonstrated that the VDAC2 was identified as an apoptosis-related diagnostic marker for sepsis, being downregulated in sepsis patients within the GSE65682 dataset [Sun et al. DOI:10.3389/fgene.2024.1389630].